VaxGen Anthrax Vaccine Delayed
This article was originally published in The Pink Sheet Daily
Executive Summary
VaxGen expects to supply its recombinant protective antigen anthrax vaccine to the U.S. government beginning in the fourth quarter of 2006, the firm announced Nov. 1